Literature DB >> 26384114

Smith-Magenis syndrome and its circadian influence on development, behavior, and obesity - own experience.

Li Chen1, Sureni V Mullegama2, Joseph T Alaimo2, Sarah H Elsea2.   

Abstract

Smith-Magenis syndrome (SMS) is a complex genetic disorder characterized by sleep disturbance, multiple developmental anomalies, psychiatric behavior, and obesity. It is caused by a heterozygous 17p11.2 microdeletion containing the retinoic acid-induced 1 (RAI1) gene or mutation within RAI1. Sleep disorder is one of the most penetrant features of SMS. Molecular genetic studies indicate that RAI1 regulates circadian rhythm genes and when haploinsucient, causes a distorted molecular circadian network that may be the cause of the sleep disturbance and the inverted rhythm of melatonin present in most individuals with SMS. RAI1 also regulates genes involved in development, neurobehavior, and lipid metabolism. Sleep debt, daytime melatonin secretion, and environmental stress often contribute to negative behavior in persons with SMS, and food entrained circadian rhythm also influences food intake behavior and humoral signals, which also affect development and neurobehavior. The cross-talk between circadian rhythm, development, metabolism and behaviors affect the multiple phenotypic outcomes in Smith-Magenis syndrome. These findings shed light on possible effective and personalized drug treatments for SMS patients in the future.

Entities:  

Mesh:

Year:  2015        PMID: 26384114

Source DB:  PubMed          Journal:  Dev Period Med


  7 in total

1.  De Novo KAT5 Variants Cause a Syndrome with Recognizable Facial Dysmorphisms, Cerebellar Atrophy, Sleep Disturbance, and Epilepsy.

Authors:  Jonathan Humbert; Smrithi Salian; Periklis Makrythanasis; Gabrielle Lemire; Justine Rousseau; Sophie Ehresmann; Thomas Garcia; Rami Alasiri; Armand Bottani; Sylviane Hanquinet; Erin Beaver; Jennifer Heeley; Ann C M Smith; Seth I Berger; Stylianos E Antonarakis; Xiang-Jiao Yang; Jacques Côté; Philippe M Campeau
Journal:  Am J Hum Genet       Date:  2020-08-20       Impact factor: 11.025

2.  A unique Smith-Magenis patient with a de novo intragenic deletion on the maternally inherited overexpressed RAI1 allele.

Authors:  Alessandra Sironi; Ilaria Bestetti; Maura Masciadri; Francesca Tumiatti; Milena Crippa; Chiara Pantaleoni; Silvia Russo; Stefano D'Arrigo; Donatella Milani; Lidia Larizza; Palma Finelli
Journal:  Eur J Hum Genet       Date:  2022-07-11       Impact factor: 5.351

Review 3.  RAI1 gene mutations: mechanisms of Smith-Magenis syndrome.

Authors:  Mariateresa Falco; Sonia Amabile; Fabio Acquaviva
Journal:  Appl Clin Genet       Date:  2017-11-03

4.  Young children with Down syndrome show normal development of circadian rhythms, but poor sleep efficiency: a cross-sectional study across the first 60 months of life.

Authors:  Fabian Fernandez; Casandra C Nyhuis; Payal Anand; Bianca I Demara; Norman F Ruby; Goffredina Spanò; Caron Clark; Jamie O Edgin
Journal:  Sleep Med       Date:  2017-02-10       Impact factor: 3.492

5.  Parental experiences with behavioural problems in Smith-Magenis syndrome: The need for syndrome-specific competence.

Authors:  Heidi Elisabeth Nag; Lise Beate Hoxmark; Terje Nærland
Journal:  J Intellect Disabil       Date:  2019-05-02

6.  De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.

Authors:  Francesco Vetrini; Shane McKee; Jill A Rosenfeld; Mohnish Suri; Andrea M Lewis; Kimberly Margaret Nugent; Elizabeth Roeder; Rebecca O Littlejohn; Sue Holder; Wenmiao Zhu; Joseph T Alaimo; Brett Graham; Jill M Harris; James B Gibson; Matthew Pastore; Kim L McBride; Makanko Komara; Lihadh Al-Gazali; Aisha Al Shamsi; Elizabeth A Fanning; Klaas J Wierenga; Daryl A Scott; Ziva Ben-Neriah; Vardiella Meiner; Hanoch Cassuto; Orly Elpeleg; J Lloyd Holder; Lindsay C Burrage; Laurie H Seaver; Lionel Van Maldergem; Sonal Mahida; Janet S Soul; Margaret Marlatt; Ludmila Matyakhina; Julie Vogt; June-Anne Gold; Soo-Mi Park; Vinod Varghese; Anne K Lampe; Ajith Kumar; Melissa Lees; Muriel Holder-Espinasse; Vivienne McConnell; Birgitta Bernhard; Ed Blair; Victoria Harrison; Donna M Muzny; Richard A Gibbs; Sarah H Elsea; Jennifer E Posey; Weimin Bi; Seema Lalani; Fan Xia; Yaping Yang; Christine M Eng; James R Lupski; Pengfei Liu
Journal:  Genome Med       Date:  2019-02-28       Impact factor: 11.117

Review 7.  Impact of Genetic Variations and Epigenetic Mechanisms on the Risk of Obesity.

Authors:  Martina Chiurazzi; Mauro Cozzolino; Roberta Clara Orsini; Martina Di Maro; Matteo Nicola Dario Di Minno; Antonio Colantuoni
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.